glp-1 fatty liver Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression Interplay of gut microbiota, glucagon-like

Amylin increases transport of tyrosine and tryptophan into the brain

It takes approximately 4 to 5 weeks of consistent daily dosing to reach steady-state blood levels

Truck drivers are twice as likely to have type 2 diabetes compared to the general population, and on average, they die at just 61 years old

A phase I/II clinical trial found that the most common side effects were mild and transient (Teichman et al., 2006): Injection site reactions (redness, mild swelling) Headaches Flushing or warmth Temporary water retention Joint tightness or tingling Transient fatigue or dizziness Serious adverse events are rare when the peptide is used under medical supervision at appropriate doses